Cite
HARVARD Citation
Cancelas, J. et al. (2022). Characterization and first‐in‐human clinical dose‐escalation safety evaluation of a next‐gen human freeze‐dried plasma. Transfusion. 62 (2), pp. 406-417. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cancelas, J. et al. (2022). Characterization and first‐in‐human clinical dose‐escalation safety evaluation of a next‐gen human freeze‐dried plasma. Transfusion. 62 (2), pp. 406-417. [Online].